Steris | STE - Debt


Steris reported $2.04B in Debt for its fiscal quarter ending in June of 2026.





Debt Change Date
3M USD 15B 2.45B Sep/2026
Accuray USD 170.24M 4.52M Sep/2024
Baxter International USD 9.67B 20M Jun/2026
Becton, Dickinson and Co. USD 16.81B 471M Jun/2026
Boston Scientific USD 12.62B 1.6B Jun/2026
CONMED USD 834.25M 26.62M Jun/2026
Cooper Companies USD 2.46B 39.5M Mar/2026
Dexcom USD 1.24B 154.7M Sep/2026
Ecolab USD 13.94B 20.6M Sep/2026
Edwards Lifesciences USD 598.8M 105.6M Sep/2026
Fortive USD 3.51B 4.9M Sep/2026
Getinge SEK 10.73B 141M Dec/2024
Globus Medical USD 111.19M 4.03M Jun/2026
Haemonetics USD 1.12B 50.4M Sep/2026
Idexx Laboratories USD 972.96M 123.12M Sep/2026
Inogen USD 0 0 Jun/2022
Insulet USD 962.1M 13.7M Sep/2026
Integra LifeSciences USD 2.05B 9.43M Jun/2026
Intuitive Surgical USD 0 0 Mar/2025
J&J USD 49.04B 5.95B Jun/2026
Olympus JPY 336.52B 102.64B Sep/2026
Orthofix International USD 137.23M 338K Sep/2024
Owens Minor USD 1.95B 91.18M Mar/2025
ResMed USD 825.92M 17.25M Jun/2026
Steris USD 2.04B 42.7M Jun/2026
Stryker USD 14.18B 16M Sep/2026
Tandem Diabetes Care USD 603.39M 811K Sep/2026
Teleflex USD 2.87B 186.84M Jun/2026
Thermo Fisher Scientific USD 42.55B 612M Jun/2026
Zimmer Biomet Holdings USD 7.5B 25.2M Sep/2026